APA
Zak M., Hanan E. J., Lupardus P., Brown D. G., Robinson C., Siu M., Lyssikatos J. P., Romero F. A., Zhao G., Kellar T., Mendonca R., Ray N. C., Goodacre S. C., Crackett P. H., McLean N., Hurley C. A., Yuen P., Cheng Y., Liu X., Liimatta M., Kohli P. B., Nonomiya J., Salmon G., Buckley G., Lloyd J., Gibbons P., Ghilardi N., Kenny J. R. & Johnson A. (20200921). Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. : Bioorganic & medicinal chemistry letters.
Chicago
Zak Mark, Hanan Emily J, Lupardus Patrick, Brown David G, Robinson Colin, Siu Michael, Lyssikatos Joseph P, Romero F Anthony, Zhao Guiling, Kellar Terry, Mendonca Rohan, Ray Nicholas C, Goodacre Simon C, Crackett Peter H, McLean Neville, Hurley Christopher A, Yuen Po-Wai, Cheng Yun-Xing, Liu Xiongcai, Liimatta Marya, Kohli Pawan Bir, Nonomiya Jim, Salmon Gary, Buckley Gerry, Lloyd Julia, Gibbons Paul, Ghilardi Nico, Kenny Jane R and Johnson Adam. 20200921. Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. : Bioorganic & medicinal chemistry letters.
Harvard
Zak M., Hanan E. J., Lupardus P., Brown D. G., Robinson C., Siu M., Lyssikatos J. P., Romero F. A., Zhao G., Kellar T., Mendonca R., Ray N. C., Goodacre S. C., Crackett P. H., McLean N., Hurley C. A., Yuen P., Cheng Y., Liu X., Liimatta M., Kohli P. B., Nonomiya J., Salmon G., Buckley G., Lloyd J., Gibbons P., Ghilardi N., Kenny J. R. and Johnson A. (20200921). Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. : Bioorganic & medicinal chemistry letters.
MLA
Zak Mark, Hanan Emily J, Lupardus Patrick, Brown David G, Robinson Colin, Siu Michael, Lyssikatos Joseph P, Romero F Anthony, Zhao Guiling, Kellar Terry, Mendonca Rohan, Ray Nicholas C, Goodacre Simon C, Crackett Peter H, McLean Neville, Hurley Christopher A, Yuen Po-Wai, Cheng Yun-Xing, Liu Xiongcai, Liimatta Marya, Kohli Pawan Bir, Nonomiya Jim, Salmon Gary, Buckley Gerry, Lloyd Julia, Gibbons Paul, Ghilardi Nico, Kenny Jane R and Johnson Adam. Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. : Bioorganic & medicinal chemistry letters. 20200921.